Site Search

Search market news

Find public news by keyword, exact ticker, category and date.

News Feed

1 result loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.

News 2026-09-01 11:00 UTC

AstraZeneca completes global license agreement for ZEGFROVY in lung cancer

AstraZeneca has completed a global license agreement for oral EGFR inhibitor ZEGFROVY (sunvozertinib) for lung cancer.